Pelashield vs Xeroform
ConditionSkin Graft
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
The purpose of this research study is to compare the effects (good or bad) of a new skin graft dressing (PelashieldTM) compared to the one traditionally used (Xeroform).
Eligibility criteria
Qualifiers
Undergoing split-thickness skin graft harvest, with a donor site sufficiently large to allow division into two comparable halves for randomized dressing application.
Donor site located in an area amenable to standardized photography and serial appearance assessment.
Ability to provide informed consent.
Willingness and ability to participate in scheduled follow-up visits for donor-site assessment, including standardized photography.
Disqualifiers
Inability, or anticipated inability, to reliably report pain within 1hour (or in recovery room) after surgery
Known allergy or hypersensitivity to lidocaine, silver-containing dressings, or other components of the study dressings.
Donor sites that are too small, irregularly shaped, or anatomically unsuitable to allow division into two comparable treatment halves.
Pre-existing skin disease at or adjacent to the donor-site region that may affect wound healing or scar appearance
Trial design
Treatments tested in this trial
- Pelashield
- Xeroform
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov